Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

BACKGROUND AND PURPOSE Mutation of the neurofibromatosis type 1 (NF-1) gene may be associated with abnormal growth control in the brain. Because macrocephaly could be a sign of abnormal brain development and because 30% to 50% of children with NF-1 display macrocephaly in the absence of hydrocephalus, we sought to determine the relationship between macrocephaly and other brain abnormalities in young subjects with NF-1. These subjects were free of brain tumor, epilepsy, or other obvious neurologic problems. METHODS We prospectively screened 18 neurologically asymptomatic subjects with NF-1, ages 6 to 16 years, using clinical measures, psychometric testing, conventional MR imaging, and quantitative MR imaging to measure T1. RESULTS Cranial circumference was 2 or more SDs above the age norm in seven (39%) of 18 subjects, a frequency of macrocephaly 17-fold higher than normal. Conventional MR imaging showed abnormalities in all 18 children, although there were more extensive abnormalities in subjects with macrocephaly. Macrocephaly in NF-1 was associated with enlargement of multiple brain structures, and brain T1 in macrocephalic subjects was reduced with respect to controls in the genu, frontal white matter, caudate, putamen, thalamus, and cortex. In normocephalic subjects, T1 was reduced only in the genu and splenium. Volumetric analysis showed that macrocephaly was associated specifically with enlargement of white matter volume. CONCLUSION Neurologically asymptomatic children with NF-1 showed macrocephaly, cognitive deficit, enlarged brain structures, and abnormally low brain T1. Macrocephaly in children with NF-1 may be associated with characteristic alterations in brain development, marked by more widespread and significant changes in T1, greater enlargement of midline structures, and greater volume of white matter.

[1]  J. Friedman,et al.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. , 1997, American journal of medical genetics.

[2]  S. Huson,et al.  Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales , 1988 .

[3]  K. North,et al.  Specific learning disability in children with neurofibromatosis type 1 , 1994, Neurology.

[4]  K. Yamashita,et al.  Development and aging of brain midline structures: assessment with MR imaging. , 1989, Radiology.

[5]  E. Reiman,et al.  Positron Emission Tomography in Children With Neurofibromatosis-1 , 1997, Journal of child neurology.

[6]  K. Krishnan,et al.  MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. , 1996, Neuroreport.

[7]  R. Ferner,et al.  Intellectual impairment in neurofibromatosis 1 , 1996, Journal of the Neurological Sciences.

[8]  A. Zvulunov,et al.  Neurofibromatosis Type 1 in Childhood: Evaluation of Clinical and Epidemiologic Features as Predictive Factors for Severity , 1998, Clinical pediatrics.

[9]  R. Mulhern,et al.  Subtle brain abnormalities in children with sickle cell disease: Relationship to blood hematocrit , 1999, Annals of neurology.

[10]  D. Gutmann,et al.  Recent insights into neurofibromatosis type 1: clear genetic progress. , 1998, Archives of neurology.

[11]  J. Dambrosia,et al.  Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. , 1989, American journal of diseases of children.

[12]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.

[13]  D. Wechsler Wechsler Intelligence Scale for Children , 2020, Definitions.

[14]  W. Reddick,et al.  A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors. , 1998, Magnetic resonance imaging.

[15]  W. Reddick,et al.  Statistical error mapping for reliable quantitative T1 imaging , 1996, Journal of magnetic resonance imaging : JMRI.

[16]  D. Gutmann,et al.  Developmental regulation of a neuron‐specific neurofibromatosis 1 isoform , 1999, Annals of neurology.

[17]  A. Barkovich,et al.  Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. , 1996, AJNR. American journal of neuroradiology.

[18]  G. Scotti,et al.  Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. , 1995, AJNR. American journal of neuroradiology.

[19]  W. Kaufmann,et al.  Thalamic involvement in neurofibromatosis type 1: Evaluation with proton magnetic resonance spectroscopic imaging , 2000, Annals of neurology.

[20]  R. Steen,et al.  Age‐related changes in proton T1 values of normal human brain , 1995, Journal of magnetic resonance imaging : JMRI.

[21]  S. Ozonoff,et al.  Cognitive impairment in neurofibromatosis type 1. , 1999, American journal of medical genetics.

[22]  D. Norman,et al.  Neurofibromatosis types 1 and 2: cranial MR findings. , 1989, Radiology.

[23]  Linda J. Schuerholz,et al.  Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. , 1996, American journal of medical genetics.

[24]  B. Moore,et al.  Brain volume in children with neurofibromatosis type 1 , 2000, Neurology.

[25]  J. I. P. James,et al.  Recognizable Patterns of Human Malformation. Genetic, Embryologic and Clinical Aspects , 1971 .

[26]  Edwin N. Cook,et al.  Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks , 1997, IEEE Transactions on Medical Imaging.

[27]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.

[28]  B. Cohen Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 2nd Ed. , 1992 .

[29]  R. Bryan,et al.  Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. , 1994, AJNR. American journal of neuroradiology.

[30]  A. Barkovich,et al.  Evolution of white matter lesions in neurofibromatosis type 1: MR findings. , 1992, AJR. American journal of roentgenology.

[31]  W. Reddick,et al.  Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI , 1998, Journal of magnetic resonance imaging : JMRI.

[32]  W E Reddick,et al.  Hybrid artificial neural network segmentation of precise and accurate inversion recovery (PAIR) images from normal human brain. , 2000, Magnetic resonance imaging.

[33]  F. Collins,et al.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.

[34]  G. Ramsby,et al.  Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. , 1998, Archives of neurology.

[35]  W E Reddick,et al.  Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. , 1997, AJNR. American journal of neuroradiology.

[36]  D. Gutmann,et al.  Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia , 1996, Journal of neuroscience research.

[37]  R. Steen,et al.  Precise and accurate measurement of proton T1 in human brain in vivo: Validation and preliminary clinical application , 1994, Journal of magnetic resonance imaging : JMRI.

[38]  D. Grobbee,et al.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital. , 1998, Journal of medical genetics.

[39]  W. Reddick,et al.  More than meets the eye: significant regional heterogeneity in human cortical T1. , 2000, Magnetic resonance imaging.

[40]  W E Reddick,et al.  Correction of errors caused by imperfect inversion pulses in MR imaging measurement of T1 relaxation times. , 1998, Magnetic resonance imaging.

[41]  R. Hughes,et al.  MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[42]  D. Shucard,et al.  The significance of MRI abnormalities in children with neurofibromatosis , 1989, Neurology.

[43]  P. Griffiths,et al.  Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential? , 1999, Pediatrics.

[44]  P. Rakić,et al.  Development of the corpus callosum and cavum septi in man , 1968, The Journal of comparative neurology.

[45]  W. Reddick,et al.  Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. , 1997, Magnetic resonance imaging.

[46]  B. Moore,et al.  Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis , 1996, Neurology.

[47]  K. Jones,et al.  Smith's Recognizable Patterns of Human Malformation , 1996 .